SEARCH RESULTS FOR: ("apk報毒處理[Contact Telegram: crmeb8].lbk")(12000 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Spinal Jaxx Implant, 7Hx12Wx21L mm
NEUROPRO SPINAL JAXX INC.
100001-502
In Commercial Distribution

  • 00818956020016 ()

  • Length: 21 Millimeter
  • Width: 12 Millimeter
  • Height: 7 Millimeter
100001-502

  • Polymeric spinal interbody fusion cage
  • Metallic spinal interbody fusion cage
Spinal Jaxx Implant, 7Hx10Wx21L mm
NEUROPRO SPINAL JAXX INC.
100001-501
In Commercial Distribution

  • 00818956020009 ()

  • Height: 7 Millimeter
  • Width: 10 Millimeter
  • Length: 21 Millimeter
100001-501

  • Polymeric spinal interbody fusion cage
  • Metallic spinal interbody fusion cage
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 505
In Commercial Distribution

  • 07540270000070 ()

  • 300-425 µm


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 504
In Commercial Distribution

  • 07540270000063 ()

  • 212-300 µm


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 503L
In Commercial Distribution

  • 07540270000056 ()

  • 180-212 µm


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable dense microspheres which are available in a range of calibrated sizes. The poly-DL-lactic-co-glycolic acid (PLGA) microspheres are surface-coated with bovine collagen. Following injection, the collagen binds patient platelets resulting in a platelet-rich clot which occludes the vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 503P
In Commercial Distribution

  • 07540270000049 ()

  • 150-180 µm


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 503
In Commercial Distribution

  • 07540270000032 ()

  • 150-212 µm


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 502
In Commercial Distribution

  • 07540270000025 ()


  • Embolization particle, bioabsorbable
Occlusin 500 is a family of biodegradable, dense, hyperechoic microspheres, which are available in a range of calibrated sizes and marketed under the trade name Ekobi Embolization Microspheres. The microspheres consist of poly-DL-lactic-co-glycolic acid (PLGA) coated with bovine collagen. Following injection into the target vasculature, the collagen binds circulating platelets resulting in a platelet-rich clot which occludes the target vasculature. The microspheres slowly degrade and are removed from the body over 4-6 months.
IMBiotechnologies Ltd
Ekobi 501
In Commercial Distribution

  • 07540270000018 ()

  • 40-100 µm


  • Embolization particle, bioabsorbable
Bone Graft Matrix
COLLAGEN MATRIX, INC.
MCCP10
In Commercial Distribution

  • 00813954026879 ()

  • 10cc
MCCP10

  • Bone matrix implant, animal-derived, bioabsorbable
< 1 ... 602 603 604 605 606 ... 1000 >